AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 207 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $618,000 | -86.5% | 17,768 | -90.5% | 0.00% | -90.9% |
| Q3 2016 | $4,592,000 | -50.8% | 187,333 | -52.0% | 0.01% | -52.2% |
| Q2 2016 | $9,340,000 | -79.7% | 390,455 | -80.2% | 0.02% | -79.1% |
| Q1 2016 | $46,112,000 | -50.6% | 1,970,591 | -36.2% | 0.11% | -47.9% |
| Q4 2015 | $93,290,000 | -38.3% | 3,090,108 | -18.8% | 0.21% | -37.6% |
| Q3 2015 | $151,241,000 | -16.7% | 3,806,717 | +44.9% | 0.34% | -7.1% |
| Q2 2015 | $181,458,000 | +168.5% | 2,627,552 | +112.5% | 0.36% | +169.6% |
| Q1 2015 | $67,583,000 | +44.3% | 1,236,417 | +12.5% | 0.14% | +40.6% |
| Q4 2014 | $46,829,000 | +55.4% | 1,098,762 | +16.3% | 0.10% | +50.0% |
| Q3 2014 | $30,136,000 | +1011.6% | 944,412 | +621.8% | 0.06% | +966.7% |
| Q2 2014 | $2,711,000 | – | 130,839 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 1,299,994 | $12,220,000 | 2.19% |
| Camber Capital Management LP | 8,780,000 | $82,532,000 | 2.18% |
| Palo Alto Investors LP | 3,003,875 | $28,236,000 | 1.55% |
| ARMISTICE CAPITAL, LLC | 4,120,000 | $38,728,000 | 1.40% |
| Permanens Capital L.P. | 359,311 | $3,378,000 | 1.17% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 31,582 | $297,000 | 0.21% |
| BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $3,271,000 | 0.20% |
| Teza Capital Management LLC | 20,300 | $191,000 | 0.11% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 767,135 | $7,211,000 | 0.08% |
| Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $365,000 | 0.04% |